Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;11(12):3003-3005.
doi: 10.1007/s13300-020-00942-7. Epub 2020 Oct 14.

Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Affiliations

Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Dimitrios Patoulias et al. Diabetes Ther. 2020 Dec.
No abstract available

Keywords: Diabetes mellitus; Pandemic; SARS-CoV-2; SGLT2 inhibitors.

PubMed Disclaimer

References

    1. Bossi AC, Forloni F, Colombelli PL. Lack of efficacy of SGLT2-i in severe pneumonia related to novel coronavirus (nCoV) infection: no little help from our friends. Diabetes Ther. 2020;11:1605–1606. doi: 10.1007/s13300-020-00844-8. - DOI - PMC - PubMed
    1. Dalan R, Ang LW, Tan WYT, et al. The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study. Eur Heart J Cardiovasc Pharmacother. 2020;2020:pvaa098. doi: 10.1093/ehjcvp/pvaa098. - DOI - PMC - PubMed
    1. Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. doi: 10.1001/jama.2016.0291. - DOI - PubMed
    1. Ssentongo P, Ssentongo AE, Heilbrunn ES, et al. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS One. 2020;15:e0238215. doi: 10.1371/journal.pone.0238215. - DOI - PMC - PubMed
    1. Cowie MR, Fisher M. SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control. Nat Rev Cardiol. 2020 doi: 10.1038/s41569-020-0406-8. - DOI - PubMed

LinkOut - more resources